CLINICAL TRIALS BY STATE

Clinical Trials in Iowa

12+ recruiting studies in Iowa, sourced in real time from ClinicalTrials.gov and displayed in plain English.

BROWSE BY CONDITION IN IOWA

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN IOWA

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

NCT07293351 · New Haven, Local Institution - 0117
RECRUITINGNA

Single-Sided Deafness and Asymmetric Hearing Loss

NCT04506853 · Chicago, Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITINGPhase 3

E-Mindfulness Approaches for Living After Breast Cancer

NCT06748222 · Phoenix, Mayo Clinic Hospital in Arizona
RECRUITINGPhase 2

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

NCT04840602 · Tucson, Banner University Medical Center - Tucson
RECRUITINGPhase 3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

NCT06141486 · Birmingham, Alabama Neurology Associates- Site Number : 8400115
RECRUITINGPhase 3

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

NCT07038200 · Orange, University of California Irvine
RECRUITINGPhase 3

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

NCT06948214 · Birmingham, Lumos Pharma Investigational Site
RECRUITINGEARLY/Phase 1

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

NCT05917587 · Iowa City, University of Iowa
RECRUITINGPhase 1

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893 · Duarte, City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
RECRUITINGPhase 2

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

NCT04858334 · Anchorage, Anchorage Associates in Radiation Medicine
RECRUITINGPhase 3

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

NCT03488693 · Fairbanks, Fairbanks Memorial Hospital
RECRUITINGPhase 3

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

NCT06129864 · Birmingham, Research Site

COMMON QUESTIONS

How many clinical trials are available in Iowa?

There are currently 12+ recruiting clinical trials in Iowa listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in Iowa?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in Iowa free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in Iowa?

Iowa hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington